medicine. NEngf iMed2003;308:50-58. 36. 29. Khoury MA Berg A, Coates R, Evans J, Teutsch SM, Bradley LA. The evidence dilemma in genomic medicine. Health Aff (Millwooc02008;27:16CO-I611. GREEN cid I ACMG recommendations on incidental findings Khoury M.I. Public health genomics: the end of the beginning.

f). 2. Kesselheim AS, Tan YT. Avom J. The roles of academia, rare diseases. and repurposing in the development of the most transforma- tive drugs. Health Aff (Millwood) 2015:34: 256-93. 3. Downing NS. Aminawung JA, Shah ND. Krumholz HM. Ross JS. Clinical trial evi- dence supporting FDA approval of novel